Nureca Ltd

Nureca, a microcap in the medical equipment sector, achieved a new 52-week high of Rs. 447, reflecting strong momentum with a 12.81% gain over two days. The stock is trading above key moving averages and has outperformed the Sensex over the past year, indicating a solid market position.

Nureca, a microcap medical equipment company, has achieved a new 52-week high of Rs. 423, reflecting strong trading momentum with a 24.75% gain over two days. The stock is currently above multiple moving averages, indicating robust short-term performance, despite a one-year decline compared to the Sensex.

Nureca, a microcap company in the medical equipment industry, reported flat financial results for the quarter ending September 2024. While net sales showed a positive growth of 37.2%, profit after tax (PAT) fell by -436.8%. MarketsMOJO has given a 'Sell' call for Nureca's stock, with investors and analysts closely monitoring its performance.

Nureca, a microcap company in the medical equipment industry, has announced its financial results for the quarter ending June 2024. While the company's Profit After Tax has shown significant growth, its Net Sales have fallen and Non Operating Income is a cause for concern. Investors should carefully evaluate these factors before making any investment decisions.

Nureca, a microcap company in the medical equipment industry, has reported a negative performance in the quarter ending March 2024, with a decrease in net sales and profit after tax. This has resulted in a 'Strong Sell' rating from MarketsMOJO, indicating a decline in the company's overall financial health and a concerning trend for investors.

Nureca, a microcap company in the medical equipment industry, has recently hit a 52-week low with its stock trading at Rs 265.25 on March 28, 2024. According to MarketsMOJO, the stock is currently rated as a 'Strong Sell' and has been underperforming the sector by -1.5%. It has also been on a downward trend for the past four days, trading below its moving averages. In the past year, Nureca's stock has declined by -12.02%, while the overall market has seen a growth of 27.86%. Investors should conduct thorough research and seek professional advice before making any investment decisions.

Nureca, a microcap company in the medical equipment industry, has seen a dip in its stock price, hitting a 52-week low of Rs. 282.05 on March 27, 2024. The company's performance has been lower than the overall market, and it is currently trading below its moving averages. Investors should carefully consider all information before making any investment decisions.

Nureca, a microcap company in the medical equipment industry, has seen a decline in its stock price, reaching a 52-week low of Rs 283.45 on March 26, 2024. This has resulted in a Strong Sell call by MarketsMOJO. The stock is currently trading below its moving averages and has underperformed the sector. Investors should conduct their own research before making any investment decisions.

Nureca, a microcap company in the medical equipment industry, has seen a dip in its stock price, hitting a 52-week low of Rs. 291 on March 13, 2024. This has resulted in a Strong Sell call by MarketsMOJO. The stock has underperformed the sector and has been on a downward trend for the past 7 days. Nureca's moving averages also indicate a downward trend, with a -14.49% 1-year performance compared to Sensex's 25.50%. Investors should carefully consider their options due to the company's recent struggles in the market.

Nureca, a microcap company in the medical equipment industry, has seen a decline in financial performance for the quarter ending December 2023. The company's stock has been given a 'Sell' call by MarketsMOJO due to a significant decline in profit and sales, as well as concerning trends in inventory turnover and reliance on non-operating income.

Nureca, a microcap company in the medical equipment industry, has been downgraded to a 'Sell' by MarketsMOJO due to its poor long-term growth and recent flat financial performance. The company's negative EBITDA and high valuation raise concerns for investors, despite a low debt to equity ratio and mildly bullish technical indicators.

Nureca, a microcap company in the medical equipment and supplies industry, has been downgraded to 'Sell' by MarketsMOJO due to poor long-term growth, flat recent results, and concerns about inventory management and negative EBITDA. Despite a low debt to equity ratio and potential for a bullish stock price, the company's underperformance in the market and majority of promoter shareholders raise concerns for potential investors.